R&D, Technology and Marketing

Admoral is a R&D Center that focuses on the "process development" of generic generic drugs and anti-tumor generic drugs and their intermediates.To meet the needs of customers, based on the premise of the best quality and reasonable price, establish core technology, develop the most competitive and non-infringing high-quality manufacturing process, taking into quality, safety, environmental protection, GMP standards and corporate social responsibility。

From R&D item selection, process development, production line design, GMP regulations and product sales... etc., comprehensive planning, development, technology transfer and marketing, in order to shorten the development timeline and sales risk of API manufacturers, and cooperate with API manufacturers to create mutually beneficial business opportunities.

悅德生技研究發展管理系統 悅德生技商業模式 悅德生技競爭優勢
Developed items
Item Number Product Name Indications
01 Apixaban Anticoagulant
02 Bicalutamide Metastatic prostate cancer
03 Dasatinib Chronic myeloid leukemia
04 Erlotinib HCI Non-small cell lung cancer
05 Gefitinib Non-small cell lung cancer
06 Indacaterol maleate Chronic obstructive pulmonary disease
07 Linagliptin Type 2 diabetes
08 Nilotinib HCI Blood cancer
09 Paliperidone Palmitate Mental/Mood disorders
10 Rivaroxaban Anticoagulant
11 Sorafenib Tosylate Renal cell carcinoma
12 Sunitinib Malate Gastrointestinal stromal tumors
13 Mephenoxalone Muscle relaxant